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Abstract
Background: Countries aiming for malaria elimination require a detailed understanding of the current intensity of
malaria transmission within their national borders. National household sample surveys are now being used to
define infection prevalence but these are less efficient in areas of exceptionally low endemicity. Here we present
the results of a national malaria indicator survey in the Republic of Djibouti, the first in sub-Saharan Africa to
combine parasitological and serological markers of malaria, to evaluate the extent of transmission in the country
and explore the potential for elimination.
Methods: A national cross-sectional household survey was undertaken from December 2008 to January 2009. A
finger prick blood sample was taken from randomly selected participants of all ages to examine for parasitaemia
using rapid diagnostic tests (RDTs) and confirmed using Polymerase Chain Reaction (PCR). Blood spots were also
collected on filter paper and subsequently used to evaluate the presence of serological markers (combined AMA-1
and MSP-119) of Plasmodium falciparum exposure. Multivariate regression analysis was used to determine the risk
factors for P. falciparum infection and/or exposure. The Getis-Ord G-statistic was used to assess spatial
heterogeneity of combined infections and serological markers.
Results: A total of 7151 individuals were tested using RDTs of which only 42 (0.5%) were positive for P. falciparum
infections and confirmed by PCR. Filter paper blood spots were collected for 5605 individuals. Of these 4769 showed
concordant optical density results and were retained in subsequent analysis. Overall P. falciparum sero-prevalence
was 9.9% (517/4769) for all ages; 6.9% (46/649) in children under the age of five years; and 14.2% (76/510) in the
oldest age group (≥ 50 years). The combined infection and/or antibody prevalence was 10.5% (550/4769) and varied
from 8.1% to 14.1% but overall regional differences were not statistically significant (c2 = 33.98, p = 0.3144).
Increasing age (p < 0.001) and decreasing household wealth status (p < 0.001) were significantly associated with
increasing combined P. falciparum infection and/or antibody prevalence. Significant P. falciparum hot spots were
observed in Dikhil region.
Conclusion: Malaria transmission in the Republic of Djibouti is very low across all regions with evidence of micro-
epidemiological heterogeneity and limited recent transmission. It would seem that the Republic of Djibouti has a
biologically feasible set of pre-conditions for elimination, however, the operational feasibility and the potential risks
to elimination posed by P. vivax and human population movement across the sub-region remain to be properly
established.
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Background
In Africa, some countries in the North have achieved
malaria elimination in the last 30 years (Libya in 1973,
Tunisia in 1979, and Morocco in 2010) and the majority
of the region is largely regarded as malaria free despite a
few disputed residual foci in Algeria and Egypt. Elimina-
tion, however, poses a major challenge in the majority
of countries in Africa owing to the intrinsically high
transmission intensity within each country’s national
borders [1] or in the cases of low transmission areas,
threats posed by neighbouring high transmission coun-
tries [2], operational constraints posed by fragile health
systems that may not reach remote foci of infection [2],
the sophistication of current health information systems
to identify all cases of clinical and asymptomatic malaria
[3], and the ability to meet the immediate increases in
financing needs that would be diverted from other
health problems [4,5].
A recent systematic analysis of available national data
has defined possible biological threats (including current
and historical receptivity of transmission and connectiv-
ity to other countries) and operational threats (including
political stability, heath system capacity and access to
populations) to elimination across 99 malaria endemic
countries [2]. Within Africa the most technically and
operationally feasible countries, as judged by a combined
ranking, were Botswana, Swaziland, São Tomé and
Príncipe, Eritrea, and Djibouti. The Republic of Djibouti
was considered the African country with the most favor-
able combinations of biological risk and operational
requirements to reach elimination and its ranking glob-
ally was equivalent or better than many countries in the
Americas. However, several recent publications have
highlighted that despite the fact that 32 countries have
declared an elimination ambition [6] few have defined
the true biological feasibility of elimination [7] and fewer
have defined a combined biological and operational feasi-
bility assessment [6,8]. There have been limited opportu-
nities for countries to assess their technical and
operational strengths and weaknesses for elimination
unless undertaken as part of very detailed reviews of
large amounts of empirical data as implemented recently
in Zanzibar, United Republic of Tanzania [9].
National Malaria Indicator Surveys (MIS) have been
established largely to provide milestone measurements
for reaching endemic control ambitions in high to mod-
erate transmission countries, with parasite prevalence as
the main transmission indicator. In low transmission
areas this indicator is not efficient [10,11]. Here we pre-
sent the results of a recent adaptation of a standard MIS
to include a national serological survey in the Republic
of Djibouti to define the extent of transmission and
explore the possibilities of malaria elimination.
Methods
National context
The Republic of Djibouti is a small country of 23,200 Km2
located at the southern reaches of the Red Sea on the
Horn of Africa, bordered by Somaliland region of Somalia
in the South, Ethiopia in the West and South and Eritrea
in the North. It was the last French territory on mainland
Africa to gain independence in 1977 with important stra-
tegic economic and political value as a port in the Gulf of
Aden. The significance of the port at Djibouti for the
Ethiopian economy was recognized at the end of the 19th
Century when the Emperor declared Djibouti an official
outlet of Ethiopian commerce that prompted the develop-
ment of the Addis Abba-Dire Dawa-Djibouti Railway
(Figure 1). This rail link continues to be an important
physical connection to Ethiopia.
The majority of the population are represented by either
the Issas (ethnically Somalis and connected to clans across
the sub-region from Somaliland, the Ogaden, and Yemen)
or the Afars (ethnically connected to people of Ethiopia).
Other smaller groups exist including people of Arab origin
and refugees who migrated into the country during the
1980’s and 1990’s from the war-ravaged neighboring coun-
tries. The population is spatially over-dispersed with 60%
of the entire country residing in Djibouti Ville and its sub-
urbs. Five secondary urban settlements exist outside the
main city at Arta, Obock, Tadjourah, Ali Sabieh and Dikhil
(Figure 1) and are inhabited by 10% of the population; the
remaining 30% of the population live in villages or noma-
dic pastoralists scattered across 90% of the country’s semi-
arid, volcanic land surface in the hinterland. The last
census was undertaken in 2009 and it was estimated that
there were 818,159 people [12]. The country is divided
into six administrative regions.
There are few rivers but one tributary of the Awash River
feeds the inland Lake Abbé on the border with Ethiopia
and seasonal Wadis feed the extremely saline Lake Assal
which is located west of the inlet water of Ghoubet Kharab,
and is the lowest point of Africa (Figure 1). Rainfall is
sparse and erratic with average annual precipitation of
130 mm with the short rains in March to May and the
long rains in July to September. The average temperature
in the country is 30°C with the hot season from May to
September during which the north eastern monsoon
blows. Average humidity is above 60% throughout the year
around Djibouti Ville and much less inland [13].
Malaria history and priorities 2006-2010
The limited annual rainfall and extreme aridity provides
a natural barrier to stable, endemic transmission of
malaria across the majority of the Republic of Djibouti.
At the turn of the last century only two foci of malaria
transmission were regarded as significant, Ambouli and
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Ganaam, on the outskirts of Djibouti Ville [14]. Between
1910 and the early 1970’s almost no locally acquired
cases of malaria were reported in the Republic of Dji-
bouti [15,16]. From 1988 epidemics of malaria began to
appear among refugees from neighboring countries and
led to onward transmission among local resident com-
munities [14,15,17]. A study among 144 febrile indivi-
duals in 1989 in Ambouli area showed no P. falciparum
infections but exposure of about 6% to antibodies
against the merozoite stage of the parasite [18]. Ano-
pheles arabiensis is now accepted as the dominant vec-
tor of P. falciparum including areas around Djibouti
Ville as it expands to the wadis, agricultural areas and
watering holes around the Ambouli region. Some have
argued that An. arabiensis was introduced to the area
via the rail link to Ethiopia [19]. Two short malaria
peaks predominantly occur during the months of May-
June and November-December [14].
The Programme National de Lutte Contre le Paludisme
(PNLP) was established in 2006 and a National Malaria
Strategy was launched the same year which recognized a
possible “re-elimination” end game. The stated ambition
was to “interrupt the transmission of malaria and elimi-
nate the disease and its consequences to the socioeconomic
development of the country as a major public health pro-
blem in Djibouti“ [16]. Despite an anticipated over-disper-
sion of malaria risks, the aim by 2010 was “to ensure
universal coverage of the profitable interventions of preven-
tion”. These were to be achieved by increasing the propor-
tion of homes owning 2 insecticide treated nets (ITN) to
>= 90% or 60% of children below the age of 5 years pro-
tected by an ITN by 2010; introduction of larvivorous fish
and Abate for larval control; and urban fogging with insec-
ticides; and case management with first line recommen-
ded therapy for uncomplicated malaria as artesunate
and sulphadoxine-pyrimethamine combination (AS+SP)
Figure 1 Map of the Republic of Djibouti showing inland water, roads, railway, administrative regions and major settlements geo-
coded in Google Earth and obtained from DEPHA [64], showing location of clusters with persons indentified as sero-positive for P.
falciparum antibodies and/or RDT-PCR confirmed parasite positive (red) and clusters where no person identified as sero-positive or
parasite positive (green) overlaid on 1 × 1 kilometre resolution surface of aridity as defined by GlobCover [33].
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combined with increased diagnostic capacities in all health
facilities. In addition monitoring systems of health and
inter-country and cross-border collaboration were to be
established [16]. These strategies were intended to reduce
local transmission by half in the whole territory by 2010
with a view to return to zero the number of actively
detected cases of malaria and to prevent new transmission
from existent cases (stated as a pre-elimination objective).
The Republic of Djibouti was successfully awarded by the
Global Fund approximately US $ 4 million during round 6
in 2007 and approved a further award during round 9 in
2009 amounting to US $6.6 million to mount pre-elimina-
tion efforts up to 2014 [20,21].
The Djibouti 2008-2009 national MIS
Sampling
A population probability sample was used to estimate a
sample of households and clusters for each of the six
administrative regions reflecting the differences in urban
and rural settlement within each region. The estimated
required sample was 4,000 households in 160 clusters
representing an estimated 24,000 individuals. The sam-
pling indicator used to power the survey was the pro-
portion of children under the age of five years sleeping
under ITN based on the expected change from the Mul-
tiple Indicator Cluster Survey findings in 2006 [22], pre-
dicted household size and age composition, between
cluster design-effect of 1.5, 10% non-participation rate
and a precision in the estimate of +/- 8.5% derived from
a balance between optimized precision and costs [23].
The survey sample was drawn from a sampling frame of
450 urban and rural clusters (defined as census enu-
meration areas with a minimum of 150 households) pro-
vided by the Direction de la Statistique et des Etudes
Demographique (DISED) [24]. The sample was then re-
adjusted to over-sample regions outside of Djibouti Ville
by reducing the sampled clusters for Djibouti Ville to
40% of the overall sample rather than the expected
probability sample of 60% and redistribute the 20% pro-
portionately across the other less densely populated
regions of the interior. For each cluster, a household
sampling interval was selected from the sampling frame
such that if a cluster had a total of 75 households, every
third household was surveyed. The sampling interval
was updated from the village elders during the day of
survey and any necessary revisions were made. During
the survey each cluster was positioned using a hand-
held Global Positioning System (Etrex H, Garmin Inc.,
USA).
Survey procedures
A community sensitization exercise was undertaken a
week before the survey via print, radio and television
media and local women’s groups encouraging support
and participation during the survey. Training of all
survey coordinators, supervisors and investigators in
survey tools and procedures occurred during a two
week period in November 2008. The survey was under-
taken over three weeks between December 2008 and
January 2009 by eight trained teams comprised of a
team supervisor, interviewer, nurse and laboratory tech-
nician. Three of the survey teams were assigned to Dji-
bouti Ville region and one team for each of the other
regions. The survey instruments used during the house-
hold investigations were adapted from standard MIS
tools developed by the Roll Back Malaria Monitoring
and Evaluation Reference Group [24]. Important varia-
tions on the standard MIS included ensuring informa-
tion was captured on all age-groups on ITN use and
peripheral blood sampling for malaria parasite and anti-
body detection in a sub-sample of household members
of all ages.
At consenting households a de facto census was under-
taken, including information on age, sex and use of nets/
treated nets and their source. Each household head was
also interviewed about assets ownership and education. A
random sample of three household members were selected
from the household census list using a table of random
numbers and consenting individuals were asked to provide
a finger prick blood sample. The finger prick sample was
used to prepare a rapid diagnostic test (Hexagon Pf
Malaria Rapid HRPII Test (Human GmbH Inc., Germany)
or ParaHit Pf Rapid Test (ICT Diagnostics, India) to pro-
vide immediate treatment using nationally recommended
AS+SP for all positive individuals; a thick and thin blood
smear, air dried, stained using 5% Giemsa; and three
5 mm diameter drops of blood on Whatman 3 MM filter
paper labelled, prepared and stored at 4°C in dry condi-
tions using procedures described elsewhere [25]. This
household sub-sample was also interviewed about travel
histories in the last six months, duration and destination
and the presence of fever in the last 14 days and on the
day of survey.
Laboratory methods
Serological measures Serologic markers can be particu-
larly useful in areas of low endemicity, where it may be
easier to detect relatively long-lasting antibody responses
than a low prevalence of malaria infections in the human
population or infected mosquitoes [26-28]. Discs of
3.5 mm diameter which contained approximately 3 μl of
blood were punched from each filter paper blood spot
and reconstituted in low binding 0.5 ml Corning®
Costar® 96-well flat bottomed plates (Sigma-Aldrich, St.
Louis, MO, USA) [25]. A 1:100 dilution of whole blood
(equivalent to a 1:200 dilution of serum) was made by
adding 300 μl of reconstitution buffer (phosphate buf-
fered saline [PBS], 0.05% Tween-20, 0.1% sodium azide,
pH 7.2) to each well. The plate was sealed, rocked at
room temperature overnight, and stored at 4°C until
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required for the Enzyme Linked Immunoabsorbent
Assays (ELISA).
Antibodies were detected simultaneously to P. falciparum
merozoite surface protein 1-19 (MSP119) and apical mem-
brane antigen 1 (AMA-1) by ELISA using procedures
described elsewhere [25]. Antigens were obtained as full-
length recombinant proteins (AMA-1) or GST fusion pro-
teins (MSP119). Immulon 4 96-well plates (Dynatech
Laboratories, Chantilly, VA, USA) were coated with 50 μl
of a combination of P. falciparum AMA-1(3D7) and P. fal-
ciparum MSP119 (K1/Wellcome) at concentrations of 0.5
μg/ml in each well and incubated overnight at 4°C. Wells
were washed 3 times using wash buffer (PBS-Tween 20,
0.05%). 150 μl/well of blocking buffer (PBS-Tween 20, 1%
skimmed milk powder) was added to each well and the
plates were incubated at room temperature for 3 hours.
Following three washes with wash buffer, 50 μl/well of a
1:1000 dilution of sera in sample buffer (PBS-Tween 20, 1%
skimmed milk powder) was added to each well in duplicate
and incubated overnight at 4°C. Positive controls (hyper-
immune serum pool) were added in duplicate to each plate
in a 4-fold serial dilution from 1:50 to 1:51200. Two nega-
tive controls (European malaria-negative volunteer serum)
were added to each plate in duplicate at the same concen-
tration as the test serum. The plates were washed 6 times
using wash buffer and incubated with 50 μl/well of horse-
radish peroxidase-conjugated polyclonal rabbit anti-human
IgG (Dako, Roskilde, Denmark) diluted at 1:5000 in sample
buffer for 3 hours at room temperature. After a further 6
washes, the plates were developed for 15-20 minutes in the
dark by the addition of 50 μl/well of SIGMAFAST™ o-phe-
nylenediamine dihydrochloride (OPD) (Sigma-Aldrich, St.
Louis, MO, USA) substrate solution. The reaction was
stopped by adding 25 μl/well 2 M H2SO4 and the absor-
bance measured at 492 nm.
Parasitology Slides taken during the survey proved to be
of inadequate quality on reading at the National Public
Health Laboratory and at the WHO’s Regional Centre for
Excellence in Malaria Microscopy in Oman [Mauolid,
unpublished observations]. Therefore confirmation of
RDT positive and 50 randomly selected negative cases
was undertaken using Polymerase Chain Reaction (PCR)
protocols for P. falciparum.
A 1-3 mm2 spot from the filter paper was excised using
a fresh scalpel blade per sample and put into a 1.5 ml pre-
labeled tube at room temperature. The QIAamp® DNA
Mini Kit (QIAGEN Inc, Valencia, CA) was used to extract
DNA according to the manufacturer’s instructions. For
the RDT positive samples a second extraction was per-
formed using the ABI6500 semi-automated extraction sys-
tem. Five positive control samples were produced by
spotting a parasite blood culture at 40% haematocrit and
1% parasitaemia. Five negative controls were made from
non-infected blood in a similar approach. Real-time PCR
using a P. falciparum specific probe for the the small sub-
unit of rRNA (18s) gene was carried out using the forward
and reverse primers 5’-TGCCGACTAGGTGTTGGATG-
3’ and 5’ GCCCCAGAACCCAAAGACTT 3’ respectively,
and a TaqMan Minor Groove Binder (MGB) probe 5’-
FAM-CATCTTTCGAGGTGACTT-MGB-TAMRA 3’
labeled with 5’FAM (6-carboxyfluorescein) and 3’TAMRA
(6-carboxytetramethyl-rhodamine) as the reporter and
quencher, respectively. 2 μl of DNA was added to each
reaction in a final volume of 20 ml with 1000 nM each of
the forward and reverse primers, 250 nM of the TaqMan
probe, and 10 μl of TaqMan Universal master mix
(Applied Biosystems, Life Technologies Corp, Carlsbad,
CA). The PCR cycling steps were as follows: 50°C for 2
minutes, 95°C for 10 minutes, and 45 cycles of 95°C for 15
seconds and 60°C for 1 minute. All positive controls had
critical threshold (Ct) values below 34 cycles. A cutoff of
38 cycles was used to define positive samples.
Analysis
All survey data were entered by four data entry clerks
using customized data entry packages in MS Access
(Microsoft Corporation, USA) which included consis-
tency checks. A wealth index was then calculated from
household assets indicators using principal component
analysis [29]. Data were subsequently analyzed using
STATA version 11 (Statacorp LP, USA). Sampling
weights were applied due to the disproportionate selec-
tion of clusters per strata and households within each
cluster. An additional weight was developed for the para-
sitology and serology samples where at least 3 individuals
were sampled per household. The overall weights of the
samples were equal to product of the inverse of the prob-
ability of selection of a cluster, household or individual
and cluster adjusted and weighted estimates were com-
puted in STATA using the svy command. Visual display
of all cluster level attributes was undertaken using the
GPS coordinates for each cluster and displayed using
ArcGIS 9.3 (ESRI Inc. USA). Inland water bodies were
assembled from the Global Lakes and Wetlands Database
(GLWD) developed by the World Wildlife Fund [30] and
major, minor roads and railway were configured from the
National Geospatial-Intelligence Agency [31]. The Glob-
Cover Land Cover product was downloaded from the
European Space Agency website [32]. This 300 m resolu-
tion land cover dataset was derived from a time-series of
Medium Resolution Imaging Spectrometer images
acquired from December 2004 to June 2006 [33]. The
GlobCover surface was used to define clusters located in
extremely arid rural areas that have less than 4% total
vegetative cover for more than 10 months in a year and
are therefore least likely to support vector larval survival
[34,35]. Distances between sampled clusters and aridity,
main roads and railway and coastline were computed
using the Spatial Analyst function in ArcGIS 9.3.
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All duplicate Optical Density (OD) values > 0.2 which
differed by more than a factor of 1.5 were rejected. To
define sero-prevalence duplicate OD values were aver-
aged and converted to titres using the positive control
curve on each plate to normalize between plates as
described below. The mean positive control ODs were
fitted to a titration curve using a sigmoid 3-parameter
model in Prism version 5 (GraphPad Software Inc, CA,
USA). Antibody titres were estimated by the equation
described in [25]. A Gaussian mixtures model was fitted
to the sample data to determine the sero-negative and
sero-positive populations underlying the distribution of
the data [25], each with their own mean and variance.
This was done using the MCLUST procedure in the R
programming language [36]. Antibody titres were loga-
rithmically transformed to render the component distri-
butions normal. The mean plus 3 standard deviations of
the sero-negative group was used as the cut-off for sero-
positivity. A single cut-off was generated as antibodies
to both AMA-1 and MSP-119 were measured in a single
well. The sero-conversion rate (l) was estimated by fit-
ting a reversible catalytic model to the measured sero-
prevalence by age in years using maximum likelihood
methods [26,37].
PCR positivity was determined using DNA amplifica-
tion plots of the samples extracted using both the Qia-
gen and ABI methods which had good correspondence
between methods. The PCR amplification plots were
displayed and where curves crossed the critical thresh-
old for parasite densities and their controls was used to
determine sample positivity.
A multivariate regression model was fitted using the
STATA 11 svy: logistic command allowing for clustering
and weighting of the data to assess the potential predic-
tors of P. falciparum exposure and/or prevalence. The
association of this outcome measure with age, residence,
use of ITN, fever prevalence within the two weeks of
survey, distance to main roads and railway, distance to
the coast line and aridity, travel in the last six months
and wealth quintile were examined. For each predictor
the Odds Ratio (OR), 95% confidence interval (CI), and
P-values were recorded. All predictors were adjusted for
the effect of the variation between regions. A backwards
step-wise approach was used to remove the variable
with the highest non-significant P-value at each stage of
the regression until a final reduced model was achieved
with the variables that showed significant association
with P. falciparum exposure and/or infection prevalence.
To assess spatial heterogeneity the presence of hot/
cold spots of P. falciparum antibody/infection preva-
lence was examined using the Getis-Ord G-statistic [38]
and associated Z-scores were computed for each cluster
in ArcGIS 9.3 (ESRI Inc. USA) using the Spatial Statis-
tics tool. A high/low value of the G-statistic indicates
that high/low values of infection and/or exposure are
clustered within the study area. To determine the signif-
icance of these statistics, Z-scores were used. When the
G-statistic is significant, positive/negative Z-scores indi-
cate clusters of hot/cold spots.
Ethical approval
Ethical approval for the study was obtained from the
Direction de l’Epidémiologie et de l’Information Sani-
taire (DEIS) of the Republic of Djibouti. All selected
household heads were informed of the purpose of the
study and offered opportunities to refuse participation.
In addition those providing blood samples were
explained the procedures and informed written consent
signed for all those agreeing to participate.
Results
Defining parasite infection and exposure
Among the 7717 household members randomly selected
for parasitological and serological investigation 566 (7.3%)
refused participation. A total 7151 consenting individuals
in 156 clusters provided blood samples for testing the pre-
sence of infection prevalence using RDT with 42 (0.5%)
positive for P. falciparum infection (Table 1) and con-
firmed using PCR. The 50 RDT P. falciparum negative
samples were also confirmed as negative by PCR. Only
5605 (78%) samples from 129 (83%) clusters were available
for serological analysis due to interruptions to survey and
loss of filter papers. Of the successfully sampled persons,
4769 filter paper samples provided concordant OD data
for serological measures of AMA-1 and MSP19 P. falci-
parum antigen exposure (Table 1). P. falciparum sero-pre-
valence was 9.9% (n = 517) including 46 children aged less
than five years (5 infants aged less than 6 months). Sero-
prevalence generally rose with age reaching a peak of
14.2% in the age group 50 or more years with a significant
overall trend (c2 = 68.27, p= 0.0001) (Table 1; Figure 2).
The seroconversion rate (l) was estimated by fitting a
reversible catalytic model to the measured sero-prevalence
by age [26,37] and was estimated to be 0.0134 new expo-
sures per person per year (95% CI: 0.010, 0.018) or about
13 new P. falciparum exposures per 1000 persons per
year. When the P. falciparum sero-positivity and infection
prevalence data were combined for the samples that were
successfully assayed, overall infection + exposure preva-
lence was 10.5% with a significant increasing trend with
age (c2 = 67.04, p= 0.0001) (Table 1).
Analysis of risk factors and spatial heterogeneity of
parasite infection and/or exposure
The univariate regression analysis showed that there was
a statistically significant increase in combined P. falci-
parum sero-positivity and/or infection prevalence if indi-
viduals were from the poorest households compared to
those from the least poor households (Table 2). No
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Table 1 Summary by age of the prevalence of P. falciparum antibody exposures and/or infections, period prevalence of fever two-weeks from the survey day
and fever on the survey day and use of insecticide treated nets (ITN) the night prior to survey shown as cluster-adjusted and weighted percentages (95%CI)
[n/N].
P. falciparum
antibody exposurea
Proportion of individuals with P.
falciparum infectionb
P. falciparum antibody exposure and
infection prevalencec
Fever prevalence in the two weeks
prior to survey
Fever prevalence
on the day of
survey
Use of ITN
Totals 9.9
(7.5 - 12.3)
[517/4769]
0.50
(0.28 - 0.73)
[42/7151]
10.5
(8.1 - 13.0)
[550/4769]
5.2
(4.11 - 6.3)
[254/4769]
1.9
(1.4 - 2.4)
[91/4769]
14.5
(11.2 - 17.7)
[740/4769]
< 5 years 6.9
(3.7 - 10.2)
[46/649]
0.23
(0.01 - 0.45)
[4/968]
7.1
(3.9 - 10.4)
[49/649]
18.5
(12.3 - 24.7)
[110/649]
4.3
(2.3 - 6.4)
[27/649]
15.8
(10.0 - 21.6)
[114/649]
5 - 9
years
4.9
(2.8 - 6.9)
[37/703]
0.61
(-0.03 - 1.24)
[6/1015]
5.7
(3.4 - 7.9)
[43/703]
6.6
(4.5 - 8.6)
[46/703]
3.8
(2.3 - 5.2)
[26/703]
17.1
(11.8 - 22.5)
[126/703]
10 - 14
years
5.0
(2.2 - 7.9)
[23/441]
0.34
(-0.06 - 0.74)
[3/644]
5.6
(2.7 - 8.5)
[26/441]
1.9
(0.6 - 3.3)
[9/441]
0.8
(0.0 - 1.6)
[5/441]
12.6
(8.6 - 16.6)
[55/441]
15 - 34
years
11.4
(8.4 - 14.3)
[202/1626]
0.49
(0.16 - 0.82)
[14/2454]
11.9
(8.9 - 14.9)
[211/1626]
2.5
(1.7 - 3.4)
[48/1626]
0.9
(0.4 - 1.4)
[16/1626]
12.5
(9.8 - 15.4)
[236/1626]
35 - 49
years
14.0
(10.0 - 17.9)
[132/833]
0.64
(0.24 - 1.05)
[9/1283]
14.7
(10.8 - 18.8)
[141/833]
3.4
(1.8 - 5.0)
[30/833]
1.6
(0.7 - 2.6)
[14/833]
16.7
(12.3 - 21.0)
[143/833]
50 +
years
14.2
(9.7 - 18.7)
[76/510]
0.67
(0.11 - 1.23)
[6/773]
15.0
(10.4 - 19.5
[79/510]
2.2
(0.8 - 3.6)
[11/510]
0.5
(-0.0 - 1.3)
[2/510]
13.6
(9.4 - 17.8)
[66/510]
c2 for
trend
68.27, p= 0.0001 3.29, p= 0.5568 67.04, p= 0.0001 268.71, p= 0.0001 50.06, p= 0.0001 14.23, p=
0.0913
For infection prevalence the denominator is all those individuals who gave a finger prick blood sample (n = 7151). For combined infection and antibody prevalence, fever prevalence and ITN use the denominator is
the total of samples that had concordant optical density values of P. falciparum antibody AMA-1 and MSP-119 antibody exposure (n = 4769).
a Seven individuals had missing age data
b 14 individuals had missing age data
c An individual was regarded as a positive case if he/she showed presence of P. falciparum infection and/or antibodies in the blood sample. Six of the P. falciparum RDT/PCR positive were also positive for antibodies.
Three individuals who were RDT positive and PCR confirmed were not successfully assayed. Overall, however, infected individuals showed higher titre responses (mean/median = 196.2/98.8) compared to uninfected
individuals (mean/median titres = 161.3/92.2).
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significant differences were observed in prevalence of
infection and/or exposure by urban versus rural; ITN
use; previous and current fever status; proximity to arid
areas, the main roads or railway and the coastline; and
travel history in the six months prior to survey within or
outside the country (Table 2). The regions of Dikhil
(14.1%), Tadjourah (14.0%), Ali Sabieh (11.7%) and
Obock (11.1%) had the highest combined P. falciparum
infection and exposure prevalence, but the overall differ-
ences between regions was not significant (Table 2: c2 =
33.98, p= 0.3144). The multivariate regression model
showed only age of individual and wealth of household
were significantly associated with the combined P. falci-
parum infection and sero-prevalence (Table 3). An
increase in age group was associated with about 30%
increase in P. falciparum exposure and/or infection
prevalence (OR = 1.3; 95% CI = 1.2 - 1.6; p < 0.001)
(Table 3). An increase in the household wealth quintile
was associated with a 20% decrease in likelihood of an
individual being positive for P. falciparum antibodies or
infections (OR = 0.8; 95% CI = 0.7 - 0.9; p < 0.001)
(Table 3). The Getis-Ord G-statistic for spatial clustering
Figure 2 Age specific sero-prevalence plot of P. falciparum
antibodies using maximum-likelihood fits from reversible
catalytic equilibrium model [37]. The vertical axis shows the
proportion of sero-positive individuals in each age group, the
horizontal axis shows the midpoint age. Red triangles represent
observed prevalence and blue fitted line is predicted age
prevalence curve. l = 0.0134 (95% CI, 0.010 - 0.018) and r = 0.0799
(95% CI, 0.0532 - 0.1200).
Table 2 Predictors of combined P. falciparum antibody and infection prevalence shown as cluster-adjusted and
weighted percentages (95%CI) [n/N]
P. falciparum antibody exposure and infection prevalence c2 , p-value
Rural vs Urban 12.8 (7.7 - 18.0) [188/1291] vs 9.9 (7.1 - 12.6) [362/3478] 7.89, p= 0.2906
Region
Ali Sabieh 11.7 (4.1 - 19.3) [57/454]
Arta 10.5 (6.2 - 14.9) [25/222]
Dikhil 14.1 (7.0 - 21.3) [109/711]
Djibouti Ville 8.1 (4.8 - 11.4) [172/2032]
Obock 11.3 (5.6 - 17.1) [68/595]
Tadjourah 14.0 (6.0 - 21.9) [119/755] 33.98 p= 0.3144
ITN use vs not used 12.2 (6.5 - 17.8) [100/740] vs 10.30 (7.9 - 12.6 [450/4029] 2.31, p= 0.4456
Fever in last 14 days Yes vs No 9.0 (4.1 - 14.0) [26/254] vs 10.6 (8.2 - 13.1) [524/4515] 0.63, p= 0.5207
Fever on the day of survey Yes vs No 15.5 (6.3 - 24.7) [14/91] vs 10.5 (8.1 - 12.9) [536/4678] 2.35, p= 0.1780
Cluster located in arid area Yes vs No 12.0 (8.4 - 15.7) [343/2727] vs 9.7 (5.8 - 11.6) [207/2042] 13.83, p= 0.1607
≤0.1 km vs > 0.1 km to arid area 11.5 (8.2 - 14.9) [362/2987] vs 9.0 (5.7 - 12.3) [188/1782] 7.44, p= 0.3069
≤0.5 km vs >0.5 km to main road/rail 10.2 (6.7 - 13.7) [274/2456] vs 11.0 (7.6 - 14.3) [276/2313] 0.74, p= 0.7549
≤7 km vs > 7 km to the coast line 9.5 (6.7 - 12.4) [276/2466] vs 12.6 (8.3 - 17.1) [274/2303] 0.01, p= 0.9910
Travelled anywhere in the last 6 months yes vs no 10.5 (7.2 - 13.9) [60/403] vs 10.6 (7.0 - 14.1) [490/4366] 3.03, p= 0.3020
Most poor vs Least poor 15.0 (9.0 - 21.0) [171/1063] vs 6.3 (3.4 - 9.2) [64/973] 41.83, p= 0.0039
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of P. falciparum antibody/infection prevalence was signif-
icant for 5 clusters with positive Z-scores (hot spots) and
34 clusters with negative Z-scores (cold spots) while 90
clusters returned values that suggest non-significant clus-
tering (Figure 3). All the clusters of high prevalence were
located in Dikhil region while 33/34 clusters of low pre-
valence were in Djibouti Ville Region. The analysis of the
presence of cold/hot spots of parasite prevalence and
sero-prevalence separately showed no significant cold/
hot spots of the former while the pattern for the latter
was similar to that of combined parasite prevalence and
sero-prevalence (data not shown).
Discussion
We present here the results from the first national MIS in
sub-Saharan Africa to include combined measures of Pf
parasitological and serological prevalence among all age
groups, undertaken in the Republic of Djibouti. P. falci-
parum parasite prevalence was 0.5% and P. falciparum
sero-prevalence to MSP-119 and/or AMA-1 was 9.9%
(Table 2). Sero-prevalence significantly increased with age
and the countrywide P. falciparum sero-conversion rate
(l) was estimated to be approximately 13 new exposures
per 1000 persons per year. Among the 517 individuals
who were positive for P. falciparum antibodies, 46 were
children under the age of five years suggestive of recent
malaria exposure. Over 76% of these children were from
Tadjourah, Dikhil and Obock regions (data not shown).
Overall sero-prevalence in the oldest age group was below
15%. In 2008 among 2896 patients with malaria-like symp-
toms attending government run clinics with laboratory
facilities were tested for presence of infection, 119 (4.1%)
were reported positive using microscopy and majority of
these cases (74%) were seen in Djibouti Ville [PNLP,
unpublished data]. The combined PCR validated P. falci-
parum RDT positivity and sero-prevalence showed some
evidence of between region variations with Djibouti Ville
showing the lowest rates (8.1%). These regional differences
were overall not statistically significant. This study there-
fore shows that the risks of P. falciparum malaria are low
across the Republic of Djibouti but majority of clusters
surveyed, 102/129 (79%), reported at least one individual
who was positive for P. falciparum antibodies and/or per-
ipheral blood infection (Figure 3). Although between
region variations in exposure was not statistically signifi-
cant, there appeared to be micro-epidemiological hetero-
geneity in sero-prevalence with 5 clusters located in Dikhil
region showing relatively higher sero-positivity (Figure 3).
Residence, aridity, distance to major road/railway and
coastline, use of ITNs, recent and present fever histories
and travel were not statistically significant predictors of
infection and/or sero-prevalence (Table 2). Increasing age
Table 3 Multivariate regression results of the predictors of combined P. falciparum antibody exposure and/or infection
prevalence shown as cluster-adjusted and weighted Odds Ratio (95%CI) and P-value of the start full model and final
reduced model
Start Full model Final reduced model
Odds Ratio (95% CI) P-value Odds Ratio (95% CI) P-value
Age categorya 1.4 (1.2 - 1.6) 0.0001 1.4 (1.2 - 1.6) 0.0001
Urban vs Rural 0.9 (0.4 - 1.7) 0.660
ITN use vs not used 1.0 (0.6 - 1.6) 0.996
Fever in last 14 days Yes vs No 0.9 (0.6 - 1.5) 0.792
Cluster located in arid area Yes vs No 1.4 (0.8 - 2.4) 0.214
≤0.5 km vs >0.5 km to main road/railc 0.9 (0.5 - 1.5) 0.631
≤7 km vs > 7 km to the coast linec 0.8 (0.5 - 1.3) 0.406
Travelled anywhere in the last 6 months yes vs noc 1.1 (0.7 - 1.8) 0.361
Wealth quintileb 0.7 (0.6 - 0.8) 0.0001 0.8 (0.7 - 0.9) 0.0001
At each stage of the regression a predictor variable (one with the highest non-significant P-value) was removed from the model in a backwards step-wise
approach until all variables in the model had a P-value of less than 0.05.
a The age grouping shown in Table 1 was used during the regression. 14 individuals had missing age data.
b Individuals were classified into the wealth quintile of their resident household.
c Median distances were used
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and decreasing household wealth were the only two vari-
ables significantly associated with increasing P. falciparum
infection and sero-prevalence independently and in
combination.
Sero-epidemiological studies carried out in Tanzania on
AMA-1 and MSP-119 showed that the two antigens pro-
vided estimates of seroconversion rates that were indepen-
dently correlated with entomological-based estimates of
P. falciparum exposure in the same areas [26,39]. AMA-1
has highly immunogenic properties reflecting recent expo-
sure [40,41] while MSP-119 antibodies saturate over longer
periods of exposure representing cumulative risks [26].
Combining exposure to both antigens in a single ELISA
test is likely to provide a more robust measure of parasite
exposure in areas of low parasite prevalence. However
interpretation of sero-positivity from optical density values
of titres measured through ELISA has an unknown sen-
sitivity and specificity and will depend largely on the
approaches taken to classify positivity. Here we elected not
to use traditional three standard deviations above estab-
lished control sera but have used a mixture model method
which has previously been used for defining sero-positivity
to measles and rubella [42-44]. By using the population
itself to define sero-positivity we remove any bias due to
population-specific immunoglobin levels, nutritional or
co-infection history. However, defining sero-positivity still
requires further work to either define their sensitivity,
eliminate the need for a cut off or improve approaches to
defining it.
From a sampling perspective the largest limitation of the
MIS was that it was powered to detect changes in ITN
coverage and not parasite exposure. This represents a per-
ennial problem for national MIS across Africa designed to
detect increases in coverage measures and not declines in
exposure. There is a recommendation however by partners
to measure changing parasite prevalence through national
Figure 3 The location of clusters that are P. falciparum antibody/infection prevalence hot spots (red dots, n = 5), cold spots (blue
dots, n = 34) and those that don’t show significant clustering (green dots, n = 90) relative to neighbouring clusters. Significance of
clustering was analysed using the Getis-Ord G-statistic [38]. Positive Z-scores with significant G-statistic indicated hot spots while negative Z-
scores indicated cold spots. The G-statistic was computed using ArcGIS 9.3 Spatial Statistics toolbox (ESRI Inc. USA). 33/34 of the cold spots were
in Djibouti Ville while all hot spots were in Dikhil region.
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surveys every 3-5 years [45]. Using the period prevalence
of parasitaemia and/or sero-positivity and the between
cluster variability from the survey undertaken in the
Republic of Djibouti in 2008-09 we estimate that one
would require testing a total population of over 22,000 to
achieve a +/- precision of 5% within a point estimate. As
prevalence becomes rare the costs of sampling to define
parasite exposure therefore increase substantially.
The field investigations of parasite prevalence included
two types of HRP-2 RDTs specific only to P. falciparum
and these, and a random sample of 50 RDT negatives,
were validated using PCR resulting in exactly similar
results. It is widely held in the Republic of Djibouti that P.
vivax constitutes less than 5% of all malaria infections [16],
however this remains to be investigated properly as vivax
infections are often missed during routine clinical micro-
scopy [46]. We have not established P. vivax prevalence
during the national survey and due to funding constraints
we were not able to undertake large-scale PCR-based
investigations of vivax and other rare species on the filter
paper samples. All neighboring countries connected to the
Republic of Djibouti also have P. vivax transmission. P.
vivax is harder to detect, treat and eliminate [47]. The
national guidelines on malaria case-management for the
Republic of Djibouti are not clear on recommendations for
the diagnosis and treatment of vivax malaria [48].
In 2009 the Republic of Djibouti submitted a proposal to
the GFATM for five years support to achieve a malaria
pre-elimination status by 2015. About 6.6 million USD
was approved in June 2009 but the agreement is unlikely
to be signed before mid-2011 (personal communication,
The Global Fund). Our findings support the biological
possibility for elimination reported elsewhere [2] but do
not examine the operational feasibility of elimination.
Interestingly the GFATM support from round 6 and
round 9 continues to promote universal coverage of ITN
[20,21]. ITN coverage was 1.4% among children in 2006
[23] and rose in 2008-09 to 19.6% among children aged
less than 5 years, with 41.5% of households owning at least
one ITN and 14.4% of the entire population using them
the night before survey [22]. Increasing ITN coverage to
over 80% would continue to be a huge resource outlay for
little obvious biological benefit where malaria risk is intrin-
sically low and spatially over-dispersed. A more logical
approach might involve targeted vector control with com-
binations of larval and adult mosquito target interventions
in response to improved vector breeding and/or clinical
case detection and cartography [49]. Mathematical models
suggest that targeting the minority who contribute the
majority to transmission in low transmission settings is
likely to yield larger returns [50-52]. Although there was a
generally limited clustering of antibody/infection preva-
lence in Djibouti, there are 4 regions (Tadjourah, Dikhil,
Obock and Ali Sabieh) which contribute to the majority of
cases. However a migration from blanket coverage to tar-
geted intervention is predicated on a robust and timely
surveillance system transitioning from routine clinical
treatment with incomplete monthly and quarterly report-
ing to a model based on daily or weekly aggressive, infec-
tious disease surveillance supported by public awareness
campaigns and universal parasitological testing. Malaria is
not a notifiable disease in Djibouti and case reporting is
embedded within the routine health information system
which suffers from perennial under-reporting and data
quality problems typical of most health information sys-
tems in Africa [53-55]. Surveillance precedents already
exist in the Republic of Djibouti for polio and cholera and
new infectious disease surveillance initiatives are being
developed to track West Nile and Dengue viral infections
[Amar Abdo, personal communication]. Malaria surveil-
lance also needs to become an up-regulated disease
reporting system with the ability to detect, intervene and
eliminate residual foci of malaria infections as and when
they emerge. The round 9 proposal includes 0.48 million
USD to strengthen surveillance but deciding on how best
to develop and implement malaria surveillance systems for
elimination has a much weaker evidence-based platform
than ITN delivery [3].
Although travel histories in the last six months were not
associated with P. falciparum infection or sero-prevalence
in this study, human population movement is likely to be a
significant challenge to elimination in the Republic of Dji-
bouti. Several authors have highlighted the role played by
the rail route to Ethiopia in the recent re-emergence of
malaria transmission in Djibouti [14,56,57]. Between
700,000 and 1.4 million passengers use this rail route each
year [58]. Residents of Djibouti Ville often migrate during
the months of May-September to avoid the excessive heat
to Hargeisa in Somaliland or Dire-Dawa in Ethiopia. The
road from Djibouti Ville to Addis via Galafi has recently
been upgraded with funding from the World Bank and the
European Union to increase transportation of goods and
people between countries [58]. Djiboutian armed and
police forces train in Ethiopia and are stationed as part of
UN peace keeping in Cote D’Ivoire. Thousands of foreign
military personnel are stationed in Djibouti Ville and
engage in regional travel. Therefore the significance of
human population movement for the risks of imported
infectious diseases, including malaria, should not be under-
estimated and may be an important contributor to disease
hot spots in the country. Although recent reports show sig-
nificant reductions in malaria infection prevalence in Ethio-
pia [59], Eritrea [60], Somalia [61] and Yemen [62], the
connectivity between the Republic of Djibouti and these
countries demonstrates the importance of constantly
reviewing the origin and destination risks against regional
human population movement to define and contain impor-
tation risks [63]. Use of mobile phone data to track
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population movements internally and externally [63];
screening arriving passengers for malaria at the border
entry points and recording of their detailed travel history;
and redesigning household survey sampling and question-
naires to capture detailed travel histories of individuals
tested for malaria infections are possible approaches to
assessing the impact of human population movement on
malaria in Djibouti. Work is ongoing to assess the theoreti-
cal impact of human population movement on malaria
transmission in Djibouti using a combination of travel his-
tory data from surveys; air passenger origin and destination
data; and estimates of malaria risk of origin and destination
[Deepa Pindolia, Personal Communication].
Conclusion
This study demonstrates the potential of adapting stan-
dard national MIS to collect information not only on
the prevalence of malaria infections but also serological
markers of exposure which are important in determin-
ing transmission in areas of low endemicity [26]. The
financial cost associated with the materials required to
collect dry blood spots for serology and subsequent ana-
lysis were relatively small. The additional survey time as
a result of collecting the samples on the filter papers
appeared minimal. However, it was not possible to con-
duct a full cost-effectiveness analysis of this adaptation
of a standard MIS as this was beyond the scope of this
study. The biggest challenge, perhaps, is less to do with
actual cost of including a serological component in stan-
dard MIS but the expertise required to implement
ELISA to investigate exposure. This serological method
for malaria is highly specialised and currently implemen-
ted largely by research groups. Potentially, however,
training of technicians at national public health labora-
tories in malaria ELISA, as was done in Djibouti for this
study, could mitigate this constraint.
The results of the survey support the apparent low
case reporting of P. falciparum in the Republic of Dji-
bouti and at face value the country may appear to be
poised for elimination, a state enjoyed across the coun-
try between 1910 and the 1970’s [15,16]. P. falciparum
elimination would be possible if surveillance and
response to foci of infections were substantially
improved drawing on experience and systems estab-
lished for polio and other rare, notifiable infectious dis-
eases. Detailed investigations into the extent of P. vivax
transmission are also needed for a comprehensive
understanding of the possibility of elimination [47]. This
would require careful planning through a feasibility ana-
lysis as undertaken recently in Zanzibar [9] and long-
term uninterrupted political support and financing [8].
At present the national malaria control programme has
managed to secure some funding to support salaries
from the GFATM round 6 funding for a short period
but no funds since 2008 to implement any activities
[Hawa Guessod, Personal Communication]. The signing
and releasing of funds from round 9 has yet to materia-
lize although it is anticipated that a larger national sur-
vey will be undertaken in 2012 during which an RDT
that can detect both P. falciparum and P. vivax will be
used in addition to collecting blood samples on filter
papers for multi-species PCR and ELISA [Hawa Gues-
sod, Personal Communication]. This and the proposed
future studies will substantially improve our understand-
ing of malaria transmission in Djibouti, but without a
carefully defined plan, staff or funding elimination of
malaria in Djibouti remains only a biological possibility.
The threshold of parasite prevalence seen as the bench-
mark for deciding whether to move on to malaria elimi-
nation or sustain low endemic control is seen as 1%
parasite prevalence [3,11]. But to detect this level of pre-
valence requires large and expensive survey samples.
The threshold for serological markers remains unclear
although the absence of exposure among children under
the age five years would be a good indicator that a
country is approaching pre-elimination [3]. An alterna-
tive equivalent index is case incidence of 1 per 1000
persons at risk [3,26]. To reliably estimate this index,
there is need for accurate passive and active case detec-
tion data over several years [11]. This requires a prop-
erly functioning national malaria surveillance system
based on a quality assured diagnostic capacity to provide
the accurate information on whether Djibouti has
achieved the biological threshold for elimination.
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